Institution
University of North Carolina at Greensboro
Education•Greensboro, North Carolina, United States•
About: University of North Carolina at Greensboro is a education organization based out in Greensboro, North Carolina, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 5481 authors who have published 13715 publications receiving 456239 citations. The organization is also known as: UNCG & UNC Greensboro.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, the authors investigate the relationships among five behavioral conflict-handling strategies, destructive and constructive conflict, and innovation performance as perceived by 290 R & D and marketing department managers.
Abstract: In recent years, many of the basic assumptions underlying organizational conflict research have changed, drawing into question the validity of some previous research findings. Operating from the perspective that conflict is complex, multidimensional, and context specific, this research takes a fresh look at key conflict antecedents, mediators, and consequences in the context of the innovation process. The study investigates the relationships among five behavioral conflict-handling strategies, destructive and constructive conflict, and innovation performance as perceived by 290 R & D and marketing department managers. Empirical results both support and question some of the previous findings in conflict research. The results indicate that integrating, accommodating, compromising, forcing, and avoiding conflict-handling strategies can have different impacts on constructive and destructive conflict in an innovation context.
242 citations
••
TL;DR: In this article, three alternative viewpoints to account for the reactivity of self-monitoring are presented, and theoretical parsimony in positing environmental antecedents as well as consequence is provided.
Abstract: Self-monitoring is the procedure by which individuals record the occurrences of their own target behaviors. In addition to providing a source of data, self-monitoring is also used as a therapeutic strategy because it often causes reactive behavior changes in response frequency. Three alternative viewpoints to account for this reactivity are presented. Kanfer's position (1970a, 1970b, 1975, 1977) is that the self-monitoring response leads to self-evaluation and self-administered consequences that alter response frequency. Rachlin (1974) holds that the self-monitoring response cues the ultimate environmental consequences that control behavior rate. In an extension of Rachlin's view, Hayes and Nelson (1977) propose that the entire self-monitoring process (therapist instructions, training, self-recording device, self-monitoring responses) prompts the external consequences that control behavior frequency. This extension provides theoretical parsimony in positing environmental antecedents as well as consequence...
241 citations
••
TL;DR: It is demonstrated that postmenopausal women with type 2 diabetes can make comprehensive lifestyle changes that may lead to clinically significant improvements in glycemic control, some coronary heart disease risk factors, and quality of life.
Abstract: OBJECTIVE —Few multiple lifestyle behavior change programs have been designed to reduce the risk of coronary heart disease in postmenopausal women with type 2 diabetes. This study tested the effectiveness of the Mediterranean Lifestyle Program (MLP), a comprehensive lifestyle self-management program (Mediterranean low–saturated fat diet, stress management training, exercise, group support, and smoking cessation), in reducing cardiovascular risk factors in postmenopausal women with type 2 diabetes. RESEARCH DESIGN AND METHODS —Postmenopausal women with type 2 diabetes ( n = 279) were randomized to either usual care (control) or treatment (MLP) conditions. MLP participants took part in an initial 3-day retreat, followed by 6 months of weekly meetings, to learn and practice program components. Biological end points were changes in HbA 1c , lipid profiles, BMI, blood pressure, plasma fatty acids, and flexibility. Impact on quality of life was assessed. RESULTS —Multivariate ANCOVAs revealed significantly greater improvements in the MLP condition compared with the usual care group on HbA 1c , BMI, plasma fatty acids, and quality of life at the 6-month follow-up. Patterns favoring intervention were seen in lipids, blood pressure, and flexibility but did not reach statistical significance. CONCLUSIONS —These results demonstrate that postmenopausal women with type 2 diabetes can make comprehensive lifestyle changes that may lead to clinically significant improvements in glycemic control, some coronary heart disease risk factors, and quality of life.
240 citations
••
TL;DR: This work suggests that mind-wandering is best considered from a family-resemblances perspective, which entails treating it as a graded, heterogeneous construct and clearly measuring and describing the specific aspect(s) of mind-Wandering that researchers are investigating.
240 citations
••
TL;DR: Romidepsin (Istodax), a selective inhibitor of histone deacetylases (HDACs), was approved for the treatment of cutaneous T-cell lymphoma in November 2009 by the US Food and Drug Administration and analogs are sought to create synthetically accessible alternatives.
Abstract: Romidepsin (Istodax), a selective inhibitor of histone deacetylases (HDACs), was approved for the treatment of cutaneous T-cell lymphoma in November 2009 by the US Food and Drug Administration. This unique natural product was discovered from cultures of Chromobacterium violaceum, a Gram-negative bacterium isolated from a Japanese soil sample. This bicyclic compound acts as a prodrug, its disulfide bridge being reduced by glutathione on uptake into the cell, allowing the free thiol groups to interact with Zn ions in the active site of class I and II HDAC enzymes. Due to the synthetic complexity of the compound, as well as the low yield from the producing organism, analogs are sought to create synthetically accessible alternatives. As a T-cell lymphoma drug, romidepsin offers a valuable new treatment for diseases with few effective therapies.
240 citations
Authors
Showing all 5571 results
Name | H-index | Papers | Citations |
---|---|---|---|
Douglas E. Soltis | 127 | 612 | 67161 |
John C. Wingfield | 122 | 509 | 52291 |
Laurence Steinberg | 115 | 403 | 70047 |
Patrick Y. Wen | 109 | 838 | 52845 |
Mark T. Greenberg | 107 | 529 | 49878 |
Steven C. Hayes | 106 | 450 | 51556 |
Edward McAuley | 105 | 451 | 45948 |
Roberto Cabeza | 94 | 252 | 36726 |
K. Ranga Rama Krishnan | 90 | 299 | 26112 |
Barry J. Zimmerman | 88 | 177 | 56011 |
Michael K. Reiter | 84 | 380 | 30267 |
Steven R. Feldman | 83 | 1227 | 37609 |
Charles E. Schroeder | 82 | 234 | 26466 |
Dale H. Schunk | 81 | 162 | 45909 |
Kim D. Janda | 79 | 731 | 26602 |